It is one of the most basic of quality requirements.
Early-stage companies are seeking cures for diseases from heart conditions to skin cancer.
Despite the fact the average age of a healthcare facility is more than two decades old, there are plenty of modifications available to transform them into modern facilities with the level of power accessibility patients will expect in the future.
Regional demand for more equipment and sophisticated treatment is expected to grow.
As standards around interoperability emerge, now may be the time to look at the benefits of connected technologies.
Artificial intelligence is here to stay, but its ultimate success hinges on how it is deployed.
A look at where tech developments are originating and what to expect.
Procedures for design validation must address risk analysis where appropriate.
MRI-compatible pacemakers are among the technologies gaining traction.
Research and development activities to find potential treatments using next generation sequencing for various fatal conditions including melanoma, epilepsy, antibody deficiency, and other diseases have gained traction. In April, FDA finalized two guidance documents to speed up development of NGS-based tests.